Brand Name | Status | Last Update |
---|---|---|
defencath | New Drug Application | 2024-12-23 |
Expiration | Code | ||
---|---|---|---|
HEPARIN SODIUM / TAUROLIDINE, DEFENCATH, CORMEDIX | |||
2033-11-15 | GAIN | ||
2028-11-15 | NCE |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sepsis | D018805 | EFO_0001420 | A41.9 | — | — | 2 | 1 | 1 | 4 |
Infections | D007239 | EFO_0000544 | — | — | — | 2 | 1 | 1 | 4 |
Communicable diseases | D003141 | — | — | — | — | 2 | 1 | 1 | 4 |
Catheter-related infections | D055499 | — | — | — | — | 1 | 1 | 1 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | — | 1 | — | — | 1 |
Renal insufficiency | D051437 | — | N19 | — | — | 1 | — | — | 1 |
Drug common name | Taurolidine |
INN | taurolidine |
Description | Taurolidine is a thiadiazinane. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1 |
PDB | — |
CAS-ID | 19388-87-5 |
RxCUI | — |
ChEMBL ID | CHEMBL2105420 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB12473 |
UNII ID | 8OBZ1M4V3V (ChemIDplus, GSRS) |